<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Peroxisome proliferator-activated receptor-γ coactivators <z:chebi fb="0" ids="15546">PGC1</z:chebi>α and <z:chebi fb="0" ids="15546">PGC1</z:chebi>β modulate <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> biogenesis and energy homeostasis </plain></SENT>
<SENT sid="1" pm="."><plain>The function of these transcriptional coactivators is impaired in <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>We searched for transcriptomic, lipidomic, and electrophysiological alterations in <z:chebi fb="0" ids="15546">PGC1</z:chebi>β(-/-) hearts potentially associated with increased arrhythmic risk in <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic diseases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: Microarray analysis in mouse <z:chebi fb="0" ids="15546">PGC1</z:chebi>β(-/-) hearts confirmed down-regulation of genes related to oxidative phosphorylation and the electron transport chain and up-regulation of <z:mpath ids='MPATH_159'>hypertrophy</z:mpath>- and <z:mp ids='MP_0005039'>hypoxia</z:mp>-related genes </plain></SENT>
<SENT sid="4" pm="."><plain>Lipidomic analysis showed increased levels of the pro-arrhythmic and pro-inflammatory <z:chebi fb="23" ids="18059">lipid</z:chebi>, <z:chebi fb="0" ids="11230">lysophosphatidylcholine</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="15546">PGC1</z:chebi>β(-/-) mouse electrocardiograms showed <z:hpo ids='HP_0011675'>irregular heartbeats</z:hpo> and an increased incidence of polymorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> following <z:chebi fb="0" ids="6046">isoprenaline</z:chebi> infusion </plain></SENT>
<SENT sid="6" pm="."><plain>Langendorff-perfused <z:chebi fb="0" ids="15546">PGC1</z:chebi>β(-/-) hearts showed action potential alternans, early after-depolarizations, and <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="15546">PGC1</z:chebi>β(-/-) ventricular myocytes showed oscillatory resting potentials, action potentials with early and delayed after-depolarizations, and burst firing during sustained current injection </plain></SENT>
<SENT sid="8" pm="."><plain>They showed abnormal diastolic Ca(2+) transients, whose amplitude and frequency were increased by <z:chebi fb="0" ids="6046">isoprenaline</z:chebi>, and Ca(2+) currents with negatively shifted inactivation characteristics, with increased window currents despite unaltered levels of CACNA1C <z:chebi fb="40" ids="33697">RNA</z:chebi> transcripts </plain></SENT>
<SENT sid="9" pm="."><plain>Inwardly and outward rectifying <z:chebi fb="0" ids="29103">K(+)</z:chebi> currents were <z:hpo ids='HP_0000001'>all</z:hpo> increased </plain></SENT>
<SENT sid="10" pm="."><plain>Quantitiative RT-PCR demonstrated increased SCN5A, KCNA5, RYR2, and Ca(2+)-calmodulin dependent protein kinase II expression </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: <z:chebi fb="0" ids="15546">PGC1</z:chebi>β(-/-) hearts showed a lysophospholipid-induced cardiac lipotoxicity and impaired bioenergetics accompanied by an ion channel remodelling and altered Ca(2+) homeostasis, converging to produce a ventricular arrhythmic phenotype particularly during adrenergic stress </plain></SENT>
<SENT sid="12" pm="."><plain>This could contribute to the increased cardiac mortality associated with both metabolic and <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disease</z:e> attributable to lysophospholipid accumulation </plain></SENT>
</text></document>